Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease
ConditionSickle Cell Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-25
SponsorBoston Children's Hospital
About this trial
Adolescents and young adults with sickle cell disease (SCD) face challenges managing their illness and maintaining their well-being. This study proposes to test the feasibility and acceptability of a resilience-promoting intervention through a Collaborative Care Model. The primary goal is to determine with the resilience intervention (PRISM) is feasible and acceptable for adolescents and young adults with SCD. Exploratory outcomes include whether this intervention improves depression, anxiety, and pain interference.
Eligibility criteria
Qualifiers
Aged ≥ 8 and ≤ 25 years of age at baseline
Diagnosed with Sickle Cell Disease (HbSS, HbSC, HbS-Beta Thalassemia, and other related hemoglobinopathies)
Receiving Medical Care at the DFCI/BCH Blood Disorders Center.
Scored > 9 on Patient Health Questionnaire 9-item (PHQ-9) or Generalized Anxiety Disorder (GAD)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Collaborative Care Model
- Promoting Resilience in Stress Management
Treatment groups
25 Participants
are divided into 1 treatment groupSponsors and collaborators
Boston Children's Hospital
Lead sponsor
National Institutes of Health (NIH)
Collaborator
Source ClinicalTrials.gov